Department of Head and Neck Surgery, Cancer Hospital, Fudan University, Shanghai, China.
J Med Genet. 2013 Oct;50(10):689-95. doi: 10.1136/jmedgenet-2013-101687. Epub 2013 Jul 11.
Five single nucleotide polymorphisms (SNPs) were previously reported to be associated with thyroid cancer in European populations in two genome-wide association studies (GWAS): rs965513 (9q22.33), rs944289 (14q13.3), rs116909374 (14q13.3), rs966423 (2q35) and rs2439302 (8p12). Only the first two SNPs have been validated in independent populations and none were replicated in Chinese populations.
The above five SNPs were genotyped in 845 papillary thyroid cancer (PTC) and 503 benign thyroid tumour (BN) patients and 1005 controls in a Chinese population using the SNaPshot multiplex single nucleotide extension system.
Significant associations were detected among PTC and rs944289 (p=8.007e-11), rs965513 (p=1.013e-4), rs966423 (p=1.688e-3) and rs2439302 (p=1.096e-4) in a dominant model, while the rs116909374 SNP was not detected in the Chinese population. The PTC risk increased with rise in accumulative numbers of risk alleles carried by individuals (p=5.929e-13). The PTC OR of carriers of six risk alleles (1.4% of the control population) was 23.587 compared with non-risk homozygotes (1.0% of the control population, with zero risk alleles). No individuals were homozygous for all the four SNPs (carriers of eight risk alleles) and only three PTC cases were carriers of seven risk alleles. A significant association between 14q13.3 SNP rs944289T and BN was also found (p=0.0014).
Four candidate loci, rs965513 (9q22.33), rs944289 (14q13.3), rs966423 (2q35) and rs2439302 (8p12), identified by GWAS for PTC risk were confirmed in a Chinese population. The PTC risk of accumulative risk allele carriers increased with the number of risk alleles.
两项全基因组关联研究(GWAS)报道了五个单核苷酸多态性(SNP)与欧洲人群的甲状腺癌相关:rs965513(9q22.33)、rs944289(14q13.3)、rs116909374(14q13.3)、rs966423(2q35)和 rs2439302(8p12)。只有前两个 SNP 在独立人群中得到了验证,而在中国人群中没有得到复制。
在中国人群中,使用 SNaPshot 多重单核苷酸延伸系统对 845 例甲状腺乳头状癌(PTC)和 503 例良性甲状腺肿瘤(BN)患者和 1005 例对照者的上述五个 SNP 进行了基因分型。
在显性模型中,PTC 与 rs944289(p=8.007e-11)、rs965513(p=1.013e-4)、rs966423(p=1.688e-3)和 rs2439302(p=1.096e-4)之间存在显著关联,而 rs116909374 SNP 在中国人群中未检出。个体携带的风险等位基因数量增加,PTC 风险也随之增加(p=5.929e-13)。携带 6 个风险等位基因(占对照组的 1.4%)的个体的 PTC OR 为 23.587,而非风险纯合子(占对照组的 1.0%,无风险等位基因)的 OR 为 1.0%。没有个体是四个 SNP(携带 8 个风险等位基因)的纯合子,只有三个 PTC 病例是 7 个风险等位基因的携带者。在 14q13.3 SNP rs944289T 与 BN 之间也发现了显著关联(p=0.0014)。
通过 GWAS 确定的与 PTC 风险相关的四个候选基因座 rs965513(9q22.33)、rs944289(14q13.3)、rs966423(2q35)和 rs2439302(8p12)在中国人中得到了验证。累积风险等位基因携带者的 PTC 风险随风险等位基因数量的增加而增加。